Reduction in Symptoms After Laser Therapy With Acorn aHFS

A Prospective, Single-blind, Randomized, Placebo-controlled, Clinical Trial Evaluating Reduction in Severity and Duration of Symptoms After Laser Therapy With Acorn aHFS

This study evaluates the severity and duration of symptoms experienced after laser therapy comparing four post-procedure topical products. Each product is applied to an individual region of interest (5 cm diameter) on the back or décolleté according to randomization code after laser therapy. The subject, blind to the product applied to each of 4 regions of interest, assesses eight symptoms daily for 14 days. Photography is performed daily.

Inclusion Criteria:

• Male or Female
• Age: ≥18 and ≤60 years
• Any skin tone Fitzpatrick score 1-2 (light), 3-4 (medium), 5-6 (dark)
• Competent and willing to provide written, informed consent to participate in all study activities

Exclusion Criteria:

• Pregnant women
• Are participating/have participated in another interventional clinical trial in the last 30 days which may confound the results of this study, unless approved by Sponsor
• Use of retinoids 7 days prior to the procedure
• Active cutaneous infections in the treatment area
• Diseases that could inhibit healing, such as scleroderma, or other cutaneous conditions that could confound study results
• Subjects unable to communicate with the investigator and staff
• Any health condition that in the investigator's opinion should preclude participation in this study